|
FGFR1OP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.35320000053063E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54639999694339E-08 |
| Normal-vs-Stage2 |
7.92460000000883E-05 |
| Normal-vs-Stage3 |
8.784400E-04 |
| Normal-vs-Stage4 |
1.164170E-02 |
| Stage1-vs-Stage2 |
6.980400E-01 |
| Stage1-vs-Stage3 |
1.854790E-01 |
| Stage1-vs-Stage4 |
4.620200E-01 |
| Stage2-vs-Stage3 |
4.542200E-01 |
| Stage2-vs-Stage4 |
6.578400E-01 |
| Stage3-vs-Stage4 |
9.167200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.26549999660497E-08 |
| Normal-vs-AfricanAmerican |
4.382000E-04 |
| Normal-vs-Asian |
4.037400E-03 |
| Caucasian-vs-AfricanAmerican |
1.360960E-01 |
| Caucasian-vs-Asian |
8.253800E-01 |
| AfricanAmerican-vs-Asian |
5.001800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.69670000061251E-08 |
| Normal-vs-Female |
1.841290E-04 |
| Male-vs-Female |
4.320500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.85339999994694E-06 |
| Normal-vs-Extreme_Weight |
1.15650000021006E-07 |
| Normal-vs-Obese |
3.247300E-04 |
| Normal-vs-Extreme_Obese |
3.94610000000739E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.878600E-01 |
| Normal_Weight-vs-Obese |
9.060500E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.101200E-01 |
| Extreme_Weight-vs-Obese |
4.355700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.798800E-01 |
| Obese-vs-Extreme_Obese |
1.126640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.599500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.60598999999761E-05 |
| Normal-vs-Age(61-80Yrs) |
3.4314999952656E-08 |
| Normal-vs-Age(81-100Yrs) |
3.644000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.000600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.157800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.194600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.510500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.682200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.128800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.4052999985914E-08 |
| Normal-VS-Type2 PRCC |
8.08629999999866E-05 |
| Normal-VS-KIRP CIMP |
9.033700E-04 |
| Normal-VS-Unclassified PRCC |
1.215730E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.352250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.312600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.086100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.479000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.222000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.399600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.73280000032628E-07 |
| Normal-vs-N1 |
2.545800E-02 |
| Normal-vs-N2 |
2.988400E-02 |
| N0-vs-N1 |
3.339900E-02 |
| N0-vs-N2 |
8.266800E-01 |
| N1-vs-N2 |
4.458000E-01 |
|
|
